SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: May 9, 1997
-----------------------------------------------------------------
ST. JUDE MEDICAL, INC.
----------------------
(Exact Name of Registrant)
Minnesota 0-8672 41-1276891
- ------------------------ --------------------- ----------------
(State of Incorporation) (Commission File No.) (IRS Employer
Identification
Number)
One Lillehei Plaza
St. Paul, Minnesota 55117
-------------------------------------------
(Address of Principal Executive Offices)
(612) 483-2000
-----------------------------------
(Registrant's telephone number)
<PAGE>
Item 5. Other Events.
St. Jude Medical, Inc. announced on April 21, 1997 that
the Hart-Scott-Rodino waiting period for the previously announced
proposed merger of Ventritex, Inc. with and into St. Jude
Medical's wholly-owned subsidiary Pacesetter, Inc. has been
terminated. Closing of the transaction is subject, among other
things, to approval of the related merger agreement by Ventritex
stockholders at a special meeting scheduled for May 12, 1997.
Item 7. Financial Statements, Pro Forma Financial
Information and Exhibits.
(c) Exhibits.
Exhibit 1 -- Press Release issued on April 21, 1997
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: May 9, 1997 ST. JUDE MEDICAL, INC.
By: /s/ Kevin T. O'Malley
-----------------------------
Name: Kevin T. O'Malley
Title: Vice President
<PAGE>
EXHIBIT INDEX
Exhibit No. Description
- ----------- -----------
1 Press Release issued on April 21, 1997
EXHIBIT 1
FOR IMMEDIATE RELEASE:
From: St. Jude Medical, Inc.
One Lillehei Plaza
St. Paul, Minnesota 55117
Contacts:
Paul Vetter Peter Gove Steve Wilson
Investor Relations Media Relations V.P. Finance & CFO
(612) 481-7791 (612) 481-7790 (612) 481-7542
- --------------------------------------------------------------------------------
St. Paul, MN, April 21, 1997 -- St. Jude Medical, Inc. (NYSE:STJ)
announced today that the Hart-Scott-Rodino waiting period for the previously
announced proposed merger with Ventritex has been terminated. Closing of the
transaction is subject to approval by Ventritex shareholders at a special
meeting scheduled for May 12, 1997.
St. Jude Medical develops, manufactures and distributes medical devices
for the global cardiovascular market. The Company serves patients and its
physician customers worldwide with the highest quality products and services
including heart valves, cardiac rhythm management systems, specialty catheters
and other cardiovascular devices.
* * *
